Compare IART & CBLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | IART | CBLL |
|---|---|---|
| Founded | 1989 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 951.9M | 935.3M |
| IPO Year | 1996 | 2024 |
| Metric | IART | CBLL |
|---|---|---|
| Price | $14.10 | $26.31 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 12 | 8 |
| Target Price | $15.67 | ★ $31.57 |
| AVG Volume (30 Days) | ★ 1.1M | 549.6K |
| Earning Date | 10-21-2026 | 11-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 56.93 |
| EPS | ★ 0.19 | N/A |
| Revenue | N/A | ★ $89,063,000.00 |
| Revenue This Year | $0.55 | $30.06 |
| Revenue Next Year | $1.86 | $27.51 |
| P/E Ratio | $73.58 | ★ N/A |
| Revenue Growth | N/A | ★ 36.09 |
| 52 Week Low | $8.70 | $13.20 |
| 52 Week High | $20.49 | $28.89 |
| Indicator | IART | CBLL |
|---|---|---|
| Relative Strength Index (RSI) | 51.45 | 48.49 |
| Support Level | $11.96 | $22.73 |
| Resistance Level | $14.28 | $28.50 |
| Average True Range (ATR) | 0.78 | 1.59 |
| MACD | 0.20 | -0.22 |
| Stochastic Oscillator | 64.61 | 62.19 |
Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and Tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales. The company operates in United States, Europe, Asia Pacific, and Rest of the World.
CeriBell Inc is a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform designed to address the unmet needs of patients in the acute care setting. By combining proprietary, portable, and rapidly deployable hardware with sophisticated artificial intelligence (AI)-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. Its products are Point-of-Care EEG, Clarity, and EEG Portal.